Xbira - Abiraterone Acetate 250mg 120 Tablets (Zytiga) - Anticancer Medication

ABIRATERONE ACETATE 250 mg x (Xbira) 120 Tablets

$400.00 $250.00
image Prescription Required

Xbira contain Abiraterone Acetate 250 mg, a hormonal therapy used in the treatment of prostate cancer, particularly metastatic castration-resistant prostate cancer (mCRPC).

Generic Name Abiraterone Acetate
Manufacturer Cipla Ltd
Packing 120 Tablets in a Bottle
Prescribed For Prostate Cancer
Availability In Stock
Shipping to USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries.

Contact us on WhatsApp

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Benefits of ABIRATERONE ACETATE 250 mg

  • Helps slow the growth of prostate cancer cells
  • Supports treatment of advanced prostate cancer
  • May help lower androgen hormone production
  • Supports better cancer management outcomes
  • Commonly used with other cancer therapies
  • Used under medical supervision

Side Effects

  • High blood pressure
  • Fluid retention (swelling of hands, feet)
  • Low potassium levels
  • Liver enzyme abnormalities
  • Fatigue
  • Joint pain
  • Headache or dizziness

Caution

  • Take as prescribed, on an empty stomach.
  • Do not skip or stop doses.
  • Inform your doctor of liver or heart issues.
  • Monitor liver function and blood pressure.
  • Avoid grapefruit or grapefruit juice.
  • Do not share medication.
  • Store in a cool, dry place away from children.

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.

Author

Reviewed By

Dr. Abhinav Narang

Doctor of Medicine (MD) | Professional Interest in Oncology

Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.

Need assistance? Chat with us